Move follows fears over jobs and control when private equity firm CD&R entered talks to buy Opella for €16bnThe French government is to take a stake in the pharmaceutical company Sanofi’s consumer healthcare division to try to quell a backlash as the US private equity firm Clayton, Dubilier & Rice enters talks to buy the unit for €16bn (£13.3bn).Sanofi is spinning off Opella, which makes the paracetamol brand Doliprane, the laxative Dulcolax and other over-the-counter medicines. However, the revelation of talks with CD&R earlier this month prompted concerns over French jobs and the loss of control to a foreign company. Continue reading…
Source link : https://www.theguardian.com/business/2024/oct/21/france-to-take-stake-in-sanofi-unit-to-quell-backlash-over-sale-to-us-firm
Author : Jasper Jolly
Publish date : 2024-10-21 08:53:42
Copyright for syndicated content belongs to the linked Source.
France to take stake in Sanofi unit to quell backlash over sale to US firm
